Skip to main content

Table 4 Effect of liver cirrhosis, DM, and hyperlipidemia on the risk of HCC in different subgroups of patients with HBV (a) and HCV (b)

From: Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study

  1. CI confidence interval DM diabetes mellitus, HBV hepatitis B virus HCV hepatitis C virus
  2. Model adjusted for age, sex, low economic income, other comorbidities (COPD, transplant, and other malignancy) and medications listed in Table 2
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us